Abstract:Background Schizophrenia is characterised by neurotrophic, neuroelectrophysiological and cognitive dysfunction. However, there exists a paucity of research examining the association between serum brain-derived neurotrophic factor (BDNF) concentration, resting electroencephalogram (EEG) gamma activity, and cognitive impairment in individuals diagnosed with schizophrenia. Methods In this study, 87 first-episode schizophrenia patients and 75 healthy controls were assessed. Measurements were conducted to determine the levels of BDNF, resting EEG γ-activity at left and right frontal pole EEG electrodes respectively (FP1/FP2) leads, and cognitive function as assessed by the Measurement and Treatment Research to Improve Cognition in Schizophrenia MATRICS Consensus Cognitive Battery (MCCB). Comparisons were made between the patient group and the control group, revealing lower BDNF levels, lower T-scores for 7 MCCB cognitive items, and higher EEG γ-activity among patients when compared to controls. Results According to the correlation analysis, there were significant associations observed in the patient group. BDNF levels were found to be correlated with EEG γ activity as well as T-scores of speed of processing (SoP), verbal learning (VeL), and reasoning problem-solving (RPS). Moreover, EEG γ activity showed an association with both the total score of the Positive and Negative Syndrome Scale (PANSS) and T-score of SoP. These findings suggest a potential relationship between BDNF levels, EEG γ activity, cognitive domains, and clinical symptoms in individuals with first-episode schizophrenia. Conclusions In conclusion, our findings demonstrate the coexistence of neurobiochemical and electrophysiological abnormalities alongside cognitive dysfunction during the early stages of schizophrenia. These findings provide valuable insights into the mechanism of cognitive impairment in schizophrenia. By highlighting the simultaneous occurrence of these factors, our study contributes to a better understanding of the complex nature of schizophrenia and emphasizes the importance of studying its cognitive aspects.

Decreased Peripheral BDNF Levels and Cognitive Impairment in Late-Life Schizophrenia

Low BDNF is Associated with Cognitive Impairment in Chronic Patients with Schizophrenia

Brain-derived neurotrophic factor is associated with cognitive impairments in first-episode and chronic schizophrenia.

Gender difference in association of cognition with BDNF in chronic schizophrenia.

Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics.

BDNF affects the mediating effect of negative symptoms on the relationship between age of onset and cognition in patients with chronic schizophrenia

Elevated activity of superoxide dismutase in male late-life schizophrenia and its correlation with clinical symptoms and cognitive deficits

Decreased Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease: a Meta-Analysis Study (N=7277).

Diabetes mellitus, cognitive deficits and serum BDNF levels in chronic patients with schizophrenia: A case-control study

Altered BDNF levels are associated with cognitive impairment in Parkinson's disease patients with depression

Neuropsychiatric Symptoms Exacerbate the Cognitive Impairments in Patients With Late-Life Depression

Low BDNF Levels in Serum Are Associated with Cognitive Impairments in Medication-Naïve Patients with Current Depressive Episode in BD II and MDD.

Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction

Brain-derived neurotrophic factor, sex hormones and cognitive decline in male patients with schizophrenia receiving continuous antipsychotic therapy

Cognitive and Serum Bdnf Correlates of Bdnf Val66met Gene Polymorphism in Patients with Schizophrenia and Normal Controls

Sex-specific association between peripheral superoxide dismutase, BDNF and cognitive impairment in drug-naive first episode patients with schizophrenia

Cognitive Impairment in First-Episode Drug-Naïve Patients with Schizophrenia: Relationships with Serum Concentrations of Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor.

Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression

Interaction of BDNF with Cytokines in Chronic Schizophrenia.

Genetic polymorphisms of BDNF on cognitive functions in drug-naive first episode patients with schizophrenia

Correlation study of brain-derived neurotrophic factor, EEG γ activity and cognitive function in first-episode schizophrenia